<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Raynaud's Phenomenon | NICE CKS Interactive Algorithm (Oct 2024)</title>
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">
<style>
  :root {
    --blue: #2563eb;      /* Assessment */
    --purple: #7c3aed;    /* Diagnosis */
    --green: #16a34a;     /* Treatment */
    --orange: #ea580c;    /* Follow-up */
    --red: #dc2626;
    --amber: #f59e0b;
    --lightgray: #f8fafc;
    --darkgray: #1e293b;
  }
  * { margin:0; padding:0; box-sizing:border-box; }
  body { font-family: system-ui, -apple-system, sans-serif; background:var(--lightgray); color:#1f2937; line-height:1.6; }
  .container { max-width:1400px; margin:0 auto; padding:20px; display:flex; gap:30px; }
  .sidebar { position:sticky; top:20px; align-self:flex-start; width:280px; background:white; border-radius:12px; padding:24px; box-shadow:0 10px 25px rgba(0,0,0,0.1); }
  .sidebar h2 { font-size:1.4rem; margin-bottom:20px; color:var(--darkgray); }
  .progress-list { list-style:none; }
  .progress-list li { padding:14px 18px; margin:8px 0; border-radius:8px; cursor:pointer; transition:all 0.3s; font-weight:600; }
  .progress-list li.active { background:var(--blue); color:white; transform:translateX(8px); }
  .progress-list li:hover:not(.active) { background:#e0e7ff; }
  .main { flex:1; }
  h1 { font-size:2rem; margin-bottom:8px; color:var(--darkgray); }
  .subtitle { color:#64748b; font-size:1.1rem; margin-bottom:30px; }
  .card {
    background:white; border-radius:16px; overflow:hidden; box-shadow:0 10px 30px rgba(0,0,0,0.08);
    margin-bottom:30px; transition:all 0.4s cubic-bezier(0.4,0,0.2,1);
  }
  .card:hover { transform:translateY(-8px); box-shadow:0 20px 40px rgba(0,0,0,0.15); }
  .card-header {
    padding:24px 30px; cursor:pointer; display:flex; align-items:center; justify-content:space-between; font-size:1.5rem; font-weight:700; color:white; transition:0.3s;
  }
  .card-header i { font-size:1.8rem; margin-right:16px; }
  .card-header .chevron { font-size:1.4rem; transition:transform 0.4s; }
  .card.open .chevron { transform:rotate(180deg); }
  #assessment .card-header { background:var(--blue); }
  #diagnosis .card-header { background:var(--purple); }
  #treatment .card-header { background:var(--green); }
  #followup .card-header { background:var(--orange); }
  .card-body { max-height:0; overflow:hidden; transition:max-height 0.6s ease, padding 0.6s ease; background:#fafafa; }
  .card.open .card-body { max-height:3000px; padding:30px; }
  .section { margin-bottom:40px; }
  .section h3 { font-size:1.35rem; margin-bottom:16px; color:var(--darkgray); display:flex; align-items:center; gap:12px; }
  .badge { padding:6px 14px; border-radius:50px; font-size:0.85rem; font-weight:700; color:white; }
  .badge.red { background:var(--red); }
  .badge.amber { background:var(--amber); }
  .badge.green { background:#16a34a; }
  ul { padding-left:28px; margin:16px 0; }
  li { margin:8px 0; }
  .highlight { background:#fef3c7; padding:16px; border-radius:8px; border-left:5px solid #f59e0b; margin:20px 0; }
  .drug-box { background:#ecfdf5; padding:20px; border-radius:12px; border:2px solid #86efac; margin:20px 0; }
  @media (max-width: 992px) {
    .container { flex-direction:column; }
    .sidebar { width:100%; position:relative; }
  }
</style>
</head>
<body>

<div class="container">
  <!-- Sticky Progress Sidebar -->
  <aside class="sidebar">
    <h2><i class="fas fa-route"></i> Algorithm Progress</h2>
    <ul class="progress-list">
      <li data-target="assessment">1. Assessment</li>
      <li data-target="diagnosis">2. Diagnosis</li>
      <li data-target="treatment">3. Treatment & Management</li>
      <li data-target="followup">4. Follow-up</li>
    </ul>
  </aside>

  <!-- Main Content -->
  <main class="main">
    <h1>Raynaud’s Phenomenon<br>Interactive Management Algorithm</h1>
    <p class="subtitle">NICE CKS – Last revised October 2024 | From age 5 years onwards</p>

    <!-- 1. Assessment -->
    <section id="assessment" class="card">
      <div class="card-header" onclick="toggleCard(this)">
        <div><i class="fas fa-stethoscope"></i> Assessment</div>
        <i class="fas fa-chevron-down chevron"></i>
      </div>
      <div class="card-body">
        <div class="section">
          <h3><i class="fas fa-history"></i> History – key questions</h3>
          <ul>
            <li>Episodic, clearly demarcated colour change (blanching essential) triggered by cold or stress?</li>
            <li>Symmetrical attacks, sparing thumbs?</li>
            <li>Duration (typical 15–20 min after rewarming)?</li>
            <li>Numbness/paraesthesia → pain on rewarming?</li>
            <li>Age at onset (primary usually teens/20s; secondary often >30)?</li>
            <li>Family history of Raynaud’s?</li>
            <li>Symptoms suggestive of CTD (fatigue, joint stiffness/swelling, rash, dry eyes/mouth, reflux, etc.)?</li>
            <li>Smoking, occupational vibration, drugs (beta-blockers, ergot, etc.)?</li>
            <li>Impact on daily function?</li>
          </ul>
        </div>

        <div class="section">
          <h3><i class="fas fa-search"></i> Examination</h3>
          <ul>
            <li>Digits: colour, temperature, critical ischaemia signs (persistent pallor, severe pain)</li>
            <li>Digital pitting, ulceration, gangrene</li>
            <li>Nailfold capillaroscopy (dermatoscope in primary care) – abnormal = early secondary marker</li>
            <li>Sclerodactyly, puffy fingers, telangiectasia, calcinosis</li>
            <li>Peripheral pulses (asymmetrical → consider large-vessel disease)</li>
          </ul>
        </div>

        <div class="section">
          <h3><i class="fas fa-vial"></i> Investigations (primary care)</h3>
          <ul>
            <li>FBC, CRP/ESR, thyroid function</li>
            <li>ANA (titre ≥1:160 or any positive centromere/ nucleolar pattern → high risk secondary)</li>
            <li>If ANA positive or high suspicion → ENA ± specific autoantibodies</li>
          </ul>
        </div>
      </div>
    </section>

    <!-- 2. Diagnosis -->
    <section id="diagnosis" class="card">
      <div class="card-header" onclick="toggleCard(this)">
        <div><i class="fas fa-search-plus"></i> Diagnosis & Classification</div>
        <i class="fas fa-chevron-down chevron"></i>
      </div>
      <div class="card-body">
        <div class="section">
          <h3>Primary Raynaud’s (80–90%)</h3>
          <ul>
            <li>Onset <30 years, symmetrical, reversible episodes</li>
            <li>No tissue injury, no underlying disease</li>
            <li>Normal capillaroscopy, negative/low-titre ANA</li>
            <li><span class="badge green">Green – Manage in primary care</span></li>
          </ul>
        </div>

        <div class="section">
          <h3>Secondary Raynaud’s – Red flags</h3>
          <ul>
            <li>Onset >30 years</li>
            <li>Asymmetrical or very painful attacks</li>
            <li>Persistent ischaemia, digital pitting/ulceration</li>
            <li>Abnormal nailfold capillaries</li>
            <li>Positive ANA (especially ≥1:160 or specific pattern)</li>
            <li>Clinical features of CTD</li>
            <li><span class="badge amber">Amber – Refer rheumatology (urgent if ulcers or abnormal capillaries)</span></li>
          </ul>
        </div>

        <div class="section">
          <h3>Critical ischaemia</h3>
          <p class="highlight"><span class="badge red">RED – Urgent hospital admission or same-day vascular/rheumatology review</span><br>
          Persistent pallor/cyanosis, severe pain, ulceration, necrosis, gangrene</p>
        </div>
      </div>
    </section>

    <!-- 3. Treatment & Management -->
    <section id="treatment" class="card">
      <div class="card-header" onclick="toggleCard(this)">
        <div><i class="fas fa-pills"></i> Treatment & Management</div>
        <i class="fas fa-chevron-down chevron"></i>
      </div>
      <div class="card-body">

        <div class="section">
          <h3><span class="badge red">Urgent/Emergency pathway</span></h3>
          <ul>
            <li>Critical ischaemia → Admit or urgent specialist review (same week)</li>
            <li>Digital ulceration/gangrene/infection → Urgent rheumatology/vascular</li>
          </ul>
        </div>

        <div class="section">
          <h3><span class="badge amber">Referral indications</span></h3>
          <ul>
            <li>Suspected secondary Raynaud’s (especially abnormal capillaries or positive ANA)</li>
            <li>Frequent severe attacks despite maximum primary care treatment</li>
            <li>Child ≤12 years with suspected Raynaud’s</li>
            <li>Age 13–17 years requiring drug treatment → seek paediatric/paediatric rheumatology advice</li>
            <li>Occupational vibration exposure → refer occupational medicine</li>
          </ul>
        </div>

        <div class="section">
          <h3><span class="badge green">Primary care management (primary Raynaud’s)</span></h3>
          <p><strong>First-line: General measures (all patients)</strong></p>
          <ul>
            <li>Keep whole body & extremities warm (layered clothing, hats, gloves, heated gloves/feet warmers)</li>
            <li>Avoid sudden cold exposure</li>
            <li>Stop smoking, reduce caffeine</li>
            <li>Stress management/relaxation techniques</li>
            <li>Patient information: <a href="https://www.nhs.uk/conditions/raynauds/" target="_blank">NHS Raynaud’s</a> | <a href="https://www.sruk.co.uk" target="_blank">SRUK charity</a></li>
          </ul>

          <div class="drug-box">
            <h3>Drug prophylaxis (if symptoms persist & troublesome)</h3>
            <p><strong>First-line: Nifedipine sustained-release (off-label but preferred)</strong></p>
            <ul>
              <li>Adults ≥18 years: 10 mg twice daily → titrate up to 40 mg twice daily</li>
              <li>Immediate-release (licensed): 5 mg three times daily → up to 20 mg three times daily (more side-effects)</li>
              <li>Intermittent use acceptable (cold weather only)</li>
              <li>Caution: hypotension, headache, flushing, ankle swelling</li>
            </ul>
            <p><strong>Second-line (if nifedipine not tolerated):</strong> Amlodipine 5–10 mg once daily (off-label)</p>
          </div>
        </div>
      </div>
    </section>

    <!-- 4. Follow-up -->
    <section id="followup" class="card">
      <div class="card-header" onclick="toggleCard(this)">
        <div><i class="fas fa-calendar-check"></i> Follow-up & Monitoring</div>
        <i class="fas fa-chevron-down chevron"></i>
      </div>
      <div class="card-body">
        <ul>
          <li>Review response to lifestyle measures and drug treatment (if prescribed)</li>
          <li>Trial withdrawal of nifedipine annually or after warm season – many enter remission</li>
          <li>Reassess promptly if:
            <ul>
              <li>New persistent ischaemia or ulceration</li>
              <li>New features suggesting secondary cause</li>
              <li>Poor control despite maximum primary care treatment</li>
            </ul>
          </li>
          <li>Safety-net: advise patient to seek urgent review if digital pain/ischaemia worsens</li>
        </ul>
      </div>
    </section>

  </main>
</div>

<script>
function toggleCard(header) {
  const card = header.parentElement;
  card.classList.toggle('open');
}

// Sidebar click → smooth scroll
document.querySelectorAll('.progress-list li').forEach(item => {
  item.addEventListener('click', () => {
    const target = item.getAttribute('data-target');
    document.getElementById(target).scrollIntoView({ behavior: 'smooth' });
  });
});

// Intersection Observer – highlight current section in sidebar
const observer = new IntersectionObserver((entries) => {
  entries.forEach(entry => {
    if (entry.isIntersecting) {
      const id = entry.target.id;
      document.querySelectorAll('.progress-list li').forEach(li => {
        li.classList.remove('active');
        if (li.getAttribute('data-target') === id) li.classList.add('active');
      });
    }
  });
}, { threshold: 0.6 });

document.querySelectorAll('.card').forEach(card => observer.observe(card));
</script>
</body>
</html>